Quantcast

The Chris Elliott Fund Announces Webinar for Brain Tumor Patients on Insurance and Financial Resources

February 20, 2013

The second webinar of the free Brains Matter Webinar Series: “A brain tumor patient’s guide to insurance and financial resources” will be offered, February 28, 2013 in partnership with the Patient Advocate Foundation

Seattle, WA (PRWEB) February 20, 2013

The Chris Elliot Fund, a brain tumor patient advocacy organization, announces their new educational webinar on resources available to brain tumor patients regarding insurance and financial challenges. The webinar titled “A Brain Tumor Patient’s Guide to Insurance & Financial Resources” focuses on important steps to take when dealing with insurance companies over co-pays and denials, medical debt concerns, and affording expensive treatments. This information will be especially helpful for brain tumor patients but anyone affected by any type of tumor or cancer are encouraged to register.

This webinar is offered free of charge on February 28th, 2013 at 11am PST. Registration is now open at: http://bit.ly/BrainsMatterWeb2, more information is available at the Chris Elliott Fund website.

Webinar coordinator and Chris Elliott Fund Health Information Concierge, Maria Barrett says “brain tumor patients can face numerous challenges during the stages of their treatment, sometimes affecting extended family and friends. We would like to discuss important steps to take when facing these types of challenges and offer strategies that will help patients, caregivers and families navigate these potential roadblocks and make more informed decisions in their brain tumor journey. This is meant to be a starting point, arming you with the steps to take to learn more.” This webinar will be offering advice from CEF representatives as well as the Patient Advocate Foundation, an organization devoted to eliminating obstacles for patients trying to access quality healthcare.

This webinar is the second installment of their year-long Brains Matter Webinar Series offering unique educational information to help brain tumor patients along their journey of treatment. The series of webinars features several experts in the field of brain tumor/brain cancer research, treatment and care. The Brains Matter Webinar Series information is gathered from a survey of international panel of experts on the CEF´s medical advisory board. These webinars are small scale, virtual meetings offering brain tumor patients a community of caregivers, experts and survivors all working towards the goal to end brain cancer.

The Chris Elliott Fund is able to offer these vital services to brain tumor patients and caregivers through the generous support from Genentech, a biotechnology company based in San Francisco, and member of the Roche Group.

About the Patient Advocate Foundation:

Patient Advocate Foundation is a national non-profit organization that serves as an active liaison between the patient and their insurer, employer and/or creditors to resolve

insurance, job retention and/or debt crisis matters relative to their diagnosis through case managers, doctors and attorneys. Patient Advocate Foundation seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability. More information at http://www.patientadvocate.org

About the Chris Elliott Fund:

The Chris Elliott Fund (CEF) is a patient advocacy organization and national 501(c)(3) non-profit with corporate offices in Seattle, Washington, with goals to end brain cancer through education, advocacy, awareness and support. Established in 2002, CEF has grown to provide support nationally for brain cancer and brain tumor patients seeking guidance, advice, and assistance to demystify finding the absolute best course of treatment for their brain cancer or brain tumor. This has been made possible over the past 11 years through the Chris Elliott Fund´s world class call center, through raising more than $1.5 million for research advocacy and support, in establishing the Christopher Stewart Elliott Neuro-Oncology Lab for Glioblastoma at the Dana-Farber Cancer Institute in Boston, in establishing the Integrated Patient Support Program at the Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment in Seattle’s Swedish Neuroscience Institute and being a leader in funding key scientific research to end the disease. The organization and its advocates, on average, serve 500-800 patients and caregivers per month, free of charge. If we can help, please contact us at WeCare(at)EndBrainCancer(dot)com and visit our website at http://www.endbraincancer.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/2/prweb10445458.htm


Source: prweb



comments powered by Disqus